Figure 7
Comparison of overall survival between subtype I patients treated with CAF and CMF adjuvant chemotherapy. Clinical variables including age at diagnosis, TNM stages, positive lymph node number, nuclear grade, hormonal therapy and post-op radiation were compared between these two treatment groups. There were no significant differences (Additional file 1, Table S6). The results of this small sample size study are supported by a recent report on two large-scale clinical trials [32].